During the past decade, Gastroenterology Associates, PC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gastroenterology Associates, PC" are "Liver Fibrosis" (2 trials), "Nonalcoholic Fatty Liver Disease (NAFLD)" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials), "Hepatic Cirrhosis" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Gastroenterology Associates, PC" in a lesser frequency.

Most popular intervention types in "Gastroenterology Associates, PC" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BMS-986036" (2 trials) and "Mirikizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterology Associates, PC" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Gastroenterology Associates, PC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Gastroenterology Associates, PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterology Associates, PC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".